Here's the live share price of Biogen Pharmachem Industries along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Biogen Pharmachem Industries has gained 30.99% CAGR. Over the past year, the corresponding return has been -38.17%.
Biogen Pharmachem Industries’s current P/E of 42.63x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Biogen Pharmachem Industries | -1.22 | -5.81 | -11.96 | -4.71 | -37.69 | -0.41 | 30.99 |
| Tata Capital | -1.31 | -2.25 | -2.25 | -2.25 | -2.25 | -0.76 | -0.46 |
| Aditya Birla Capital | 4.06 | 14.58 | 24.47 | 73.91 | 67.87 | 38.06 | 36.9 |
| Motilal Oswal Financial Services | 1.76 | 7.65 | 9.94 | 45.41 | -0.14 | 79.99 | 47.58 |
| HDB Financial Services | -2.69 | -3.41 | -5.25 | -15.36 | -15.36 | -5.41 | -3.28 |
| Max Financial Services | 4.93 | 3.48 | 4.59 | 27.59 | 33.2 | 31.64 | 21.23 |
| 360 One Wam | -1.61 | -1.97 | 1.92 | 16.54 | 1.77 | 32.17 | 35.99 |
| Tata Investment Corporation | -2.08 | -15.42 | 13.48 | 33.4 | 15.55 | 48.44 | 55.8 |
| Cholamandalam Financial Holdings | -1.47 | 1.59 | 1.95 | 2.96 | 12.2 | 45.79 | 35.47 |
| Nuvama Wealth Management | 2.78 | 4.05 | 7.62 | 24.29 | 3.79 | 41.71 | 23.26 |
| Anand Rathi Wealth | 1.3 | 4.8 | 21.09 | 85.76 | 60.48 | 107.36 | 60.71 |
| Angel One | 4.99 | 17.98 | 2.46 | 12.11 | -8.07 | 19.06 | 50.95 |
| KFIN Technologies | 1.24 | 7.64 | 3.59 | 4.4 | 9.25 | 45.1 | 25.03 |
| JSW Holdings | 3.48 | 7.86 | -7.96 | -24.89 | 10.29 | 56.23 | 44.44 |
| Computer Age Management Services | -3.52 | 0.52 | 1.4 | 6.46 | -18.57 | 15.75 | 24.04 |
| Maharashtra Scooters | -5 | -13.58 | -1.4 | 33.68 | 35.18 | 40.63 | 36.35 |
| RRP Semiconductor | 8.24 | 48.59 | 228.02 | 1,110.95 | 12,553.71 | 822.72 | 279.35 |
| JM Financial | -3.11 | -10.55 | 2.61 | 59.16 | 8.79 | 27.18 | 15.91 |
| Prudent Corporate Advisory Services | 3.39 | -0.78 | 0.05 | 19.83 | -11.67 | 48.97 | 36.23 |
| IIFL Capital Services | -1.42 | 12.34 | 11.2 | 48.25 | -10.06 | 68.28 | 53.45 |
Over the last one year, Biogen Pharmachem Industries has declined 37.69% compared to peers like Tata Capital (-2.25%), Aditya Birla Capital (67.87%), Motilal Oswal Financial Services (-0.14%). From a 5 year perspective, Biogen Pharmachem Industries has underperformed peers relative to Tata Capital (-0.46%) and Aditya Birla Capital (36.90%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 0.83 | 0.82 |
| 10 | 0.83 | 0.82 |
| 20 | 0.84 | 0.83 |
| 50 | 0.87 | 0.86 |
| 100 | 0.91 | 0.89 |
| 200 | 0.95 | 0.95 |
In the latest quarter, Biogen Pharmachem Industries remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 100.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 07, 2025, 9:55 PM IST | Biogen Pharmachem - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2 |
| Nov 07, 2025, 9:51 PM IST | Biogen Pharmachem - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requir |
| Nov 07, 2025, 9:46 PM IST | Biogen Pharmachem - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requir |
| Nov 07, 2025, 9:41 PM IST | Biogen Pharmachem - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 7Th November 2025. |
| Oct 30, 2025, 11:59 PM IST | Biogen Pharmachem - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of |
Biogen Pharmachem Industries Ltd. is a Public Limited Listed company incorporated on 13/07/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51100GJ1995PLC026702 and registration number is 026702. Currently company belongs to the Industry of Finance & Investments. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 65.26 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biogen Pharmachem Industries is ₹0.81 as on Nov 07, 2025.
The Biogen Pharmachem Industries is operating in the Finance Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Biogen Pharmachem Industries is ₹73.11 Cr as on Nov 07, 2025.
Today’s highest and lowest price of Biogen Pharmachem Industries are ₹0.83 and ₹0.81.
The 52-week high/low is the highest and lowest price at which Biogen Pharmachem Industries stock has traded in the past 52-week or nearly a year. The 52-week high of Biogen Pharmachem Industries is ₹1.34 and 52-week low of Biogen Pharmachem Industries is ₹0.75 as on Nov 07, 2025.
The Biogen Pharmachem Industries has shown returns of 0.0% over the past day, -7.95% for the past month, -11.96% over 3 months, -38.17% over 1 year, -0.41% across 3 years, and 30.99% over 5 years.
P/E ratio of and PB ratio of Biogen Pharmachem Industries are 42.63 and 0.63 on Nov 07, 2025. While the company gives a dividend yield of 0.00 per annum.